These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26151174)

  • 41. A longitudinal assessment of sleep variables during exacerbations of chronic obstructive pulmonary disease.
    Vanaparthy R; Mota P; Khan R; Ehsan M; Qureshi A; ZuWallack R; Leidy N
    Chron Respir Dis; 2015 Nov; 12(4):299-304. PubMed ID: 26033837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with exacerbation in mild- to-moderate COPD patients.
    Kim JK; Lee SH; Lee BH; Lee CY; Kim do J; Min KH; Kim SK; Yoo KH; Jung KS; Hwang YI
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1327-33. PubMed ID: 27366060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).
    Mackay AJ; Donaldson GC; Patel AR; Singh R; Kowlessar B; Wedzicha JA
    Eur Respir J; 2014 Mar; 43(3):735-44. PubMed ID: 23988767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Husebø GR; Grønseth R; Lerner L; Gyuris J; Hardie JA; Bakke PS; Eagan TM
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
    Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study.
    Shorofsky M; Bourbeau J; Kimoff J; Jen R; Malhotra A; Ayas N; Tan WC; Aaron SD; Sin DD; Road J; Chapman KR; O'Donnell DE; Maltais F; Hernandez P; Walker BL; Marciniuk D; Kaminska M; ;
    Chest; 2019 Nov; 156(5):852-863. PubMed ID: 31150638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
    Fan VS; Ramsey SD; Make BJ; Martinez FJ
    COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1427-1437. PubMed ID: 28553095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory changes, recovery and recurrence at COPD exacerbation.
    Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
    Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline.
    Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JWH; Sadatsafavi M; Sin DD; Carter V; Price DB
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1909-1918. PubMed ID: 32821093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.
    Ferrera MC; Lopez CL; Murray S; Jain RG; Labaki WW; Make BJ; Han MK
    Ann Am Thorac Soc; 2024 Mar; 21(3):421-427. PubMed ID: 37796613
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial.
    Ritchie AI; Brill SE; Vlies BH; Finney LJ; Allinson JP; Alves-Moreira L; Wiseman DJ; Walker PP; Baker E; Elkin SL; Mallia P; Law M; Donaldson GC; Calverley PMA; Wedzicha JA
    Am J Respir Crit Care Med; 2020 Aug; 202(4):549-557. PubMed ID: 32267724
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study.
    Dal Negro RW; Wedzicha JA; Iversen M; Fontana G; Page C; Cicero AF; Pozzi E; Calverley PMA; ;
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29025888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.
    Fukuchi Y; Fernandez L; Kuo HP; Mahayiddin A; Celli B; Decramer M; Kesten S; Liu D; Tashkin D
    Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.
    Waschki B; Kirsten AM; Holz O; Mueller KC; Schaper M; Sack AL; Meyer T; Rabe KF; Magnussen H; Watz H
    Am J Respir Crit Care Med; 2015 Aug; 192(3):295-306. PubMed ID: 26020495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD.
    Pascoe S; Costa M; Marks-Konczalik J; McKie E; Yang S; Scherbovsky PS
    Respir Med; 2017 Sep; 130():20-26. PubMed ID: 29206629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of tidal EFL with exercise performance, exacerbations, and death in COPD.
    Aarli BB; Calverley PM; Jensen RL; Dellacà R; Eagan TM; Bakke PS; Hardie JA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2179-2188. PubMed ID: 28794622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
    Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
    Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study.
    Brill SE; Patel AR; Singh R; Mackay AJ; Brown JS; Hurst JR
    Respir Res; 2015 Feb; 16(1):16. PubMed ID: 25849856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.